img

Global Biochemical Befense Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends

Publisher : MRA | Format : PDF

Global Biochemical Befense Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Biochemical Befense report published by MRA Research reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2023. Global Biochemical Befense market is projected to reach US$ million in 2033, increasing from US$ million in 2023, with the CAGR of % during the period of 2023 to 2033. Demand from National Defense and Military are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Biochemical Befense industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Biochemical Befense key companies include Emergent Biosolutions, Hytest, GSK, Sanofi, PharmAthene, Bavarian Nordic, SIGA Technologies, Arbutus Biopharma and DynPort Vaccine, etc. Emergent Biosolutions, Hytest, GSK are top 3 players and held % share in total in 2023.
Biochemical Befense can be divided into Anthrax, Smallpox, Botulism and Radiation/Nuclear, etc. Anthrax is the mainstream product in the market, accounting for % share globally in 2023.
Biochemical Befense is widely used in various fields, such as National Defense, Military and Others,, etc. National Defense provides greatest supports to the Biochemical Befense industry development. In 2023, global % share of Biochemical Befense went into National Defense filed.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Biochemical Befense market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Emergent Biosolutions
Hytest
GSK
Sanofi
PharmAthene
Bavarian Nordic
SIGA Technologies
Arbutus Biopharma
DynPort Vaccine
Xoma Corporation
Ichor Medical Systems
Aeolus Pharmaceuticals
Achaogen
Elusys Therapeutics
Dynavax Technologies
Cleveland BioLabs
Soligenix
Alnylam Pharmaceuticals
Segment by Type
Anthrax
Smallpox
Botulism
Radiation/Nuclear
Others

Segment by Application


National Defense
Military
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Biochemical Befense market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Biochemical Befense introduction, etc. Biochemical Befense Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRA Research’s Conclusions of Biochemical Befense market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRA Research.

Table of Content

1 Market Overview of Biochemical Befense
1.1 Biochemical Befense Market Overview
1.1.1 Biochemical Befense Product Scope
1.1.2 Biochemical Befense Market Status and Outlook
1.2 Global Biochemical Befense Market Size Overview by Region 2018 VS 2023 VS 2033
1.3 Global Biochemical Befense Market Size by Region (2018-2033)
1.4 Global Biochemical Befense Historic Market Size by Region (2018-2023)
1.5 Global Biochemical Befense Market Size Forecast by Region (2024-2033)
1.6 Key Regions, Biochemical Befense Market Size (2018-2033)
1.6.1 North America Biochemical Befense Market Size (2018-2033)
1.6.2 Europe Biochemical Befense Market Size (2018-2033)
1.6.3 Asia-Pacific Biochemical Befense Market Size (2018-2033)
1.6.4 Latin America Biochemical Befense Market Size (2018-2033)
1.6.5 Middle East & Africa Biochemical Befense Market Size (2018-2033)
2 Biochemical Befense Market by Type
2.1 Introduction
2.1.1 Anthrax
2.1.2 Smallpox
2.1.3 Botulism
2.1.4 Radiation/Nuclear
2.1.5 Others
2.2 Global Biochemical Befense Market Size by Type: 2018 VS 2023 VS 2033
2.2.1 Global Biochemical Befense Historic Market Size by Type (2018-2023)
2.2.2 Global Biochemical Befense Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America Biochemical Befense Revenue Breakdown by Type (2018-2033)
2.3.2 Europe Biochemical Befense Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific Biochemical Befense Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America Biochemical Befense Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa Biochemical Befense Revenue Breakdown by Type (2018-2033)
3 Biochemical Befense Market Overview by Application
3.1 Introduction
3.1.1 National Defense
3.1.2 Military
3.1.3 Others
3.2 Global Biochemical Befense Market Size by Application: 2018 VS 2023 VS 2033
3.2.1 Global Biochemical Befense Historic Market Size by Application (2018-2023)
3.2.2 Global Biochemical Befense Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America Biochemical Befense Revenue Breakdown by Application (2018-2033)
3.3.2 Europe Biochemical Befense Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific Biochemical Befense Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America Biochemical Befense Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa Biochemical Befense Revenue Breakdown by Application (2018-2033)
4 Biochemical Befense Competition Analysis by Players
4.1 Global Biochemical Befense Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biochemical Befense as of 2023)
4.3 Date of Key Players Enter into Biochemical Befense Market
4.4 Global Top Players Biochemical Befense Headquarters and Area Served
4.5 Key Players Biochemical Befense Product Solution and Service
4.6 Competitive Status
4.6.1 Biochemical Befense Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Emergent Biosolutions
5.1.1 Emergent Biosolutions Profile
5.1.2 Emergent Biosolutions Main Business
5.1.3 Emergent Biosolutions Biochemical Befense Products, Services and Solutions
5.1.4 Emergent Biosolutions Biochemical Befense Revenue (US$ Million) & (2018-2023)
5.1.5 Emergent Biosolutions Recent Developments
5.2 Hytest
5.2.1 Hytest Profile
5.2.2 Hytest Main Business
5.2.3 Hytest Biochemical Befense Products, Services and Solutions
5.2.4 Hytest Biochemical Befense Revenue (US$ Million) & (2018-2023)
5.2.5 Hytest Recent Developments
5.3 GSK
5.3.1 GSK Profile
5.3.2 GSK Main Business
5.3.3 GSK Biochemical Befense Products, Services and Solutions
5.3.4 GSK Biochemical Befense Revenue (US$ Million) & (2018-2023)
5.3.5 Sanofi Recent Developments
5.4 Sanofi
5.4.1 Sanofi Profile
5.4.2 Sanofi Main Business
5.4.3 Sanofi Biochemical Befense Products, Services and Solutions
5.4.4 Sanofi Biochemical Befense Revenue (US$ Million) & (2018-2023)
5.4.5 Sanofi Recent Developments
5.5 PharmAthene
5.5.1 PharmAthene Profile
5.5.2 PharmAthene Main Business
5.5.3 PharmAthene Biochemical Befense Products, Services and Solutions
5.5.4 PharmAthene Biochemical Befense Revenue (US$ Million) & (2018-2023)
5.5.5 PharmAthene Recent Developments
5.6 Bavarian Nordic
5.6.1 Bavarian Nordic Profile
5.6.2 Bavarian Nordic Main Business
5.6.3 Bavarian Nordic Biochemical Befense Products, Services and Solutions
5.6.4 Bavarian Nordic Biochemical Befense Revenue (US$ Million) & (2018-2023)
5.6.5 Bavarian Nordic Recent Developments
5.7 SIGA Technologies
5.7.1 SIGA Technologies Profile
5.7.2 SIGA Technologies Main Business
5.7.3 SIGA Technologies Biochemical Befense Products, Services and Solutions
5.7.4 SIGA Technologies Biochemical Befense Revenue (US$ Million) & (2018-2023)
5.7.5 SIGA Technologies Recent Developments
5.8 Arbutus Biopharma
5.8.1 Arbutus Biopharma Profile
5.8.2 Arbutus Biopharma Main Business
5.8.3 Arbutus Biopharma Biochemical Befense Products, Services and Solutions
5.8.4 Arbutus Biopharma Biochemical Befense Revenue (US$ Million) & (2018-2023)
5.8.5 Arbutus Biopharma Recent Developments
5.9 DynPort Vaccine
5.9.1 DynPort Vaccine Profile
5.9.2 DynPort Vaccine Main Business
5.9.3 DynPort Vaccine Biochemical Befense Products, Services and Solutions
5.9.4 DynPort Vaccine Biochemical Befense Revenue (US$ Million) & (2018-2023)
5.9.5 DynPort Vaccine Recent Developments
5.10 Xoma Corporation
5.10.1 Xoma Corporation Profile
5.10.2 Xoma Corporation Main Business
5.10.3 Xoma Corporation Biochemical Befense Products, Services and Solutions
5.10.4 Xoma Corporation Biochemical Befense Revenue (US$ Million) & (2018-2023)
5.10.5 Xoma Corporation Recent Developments
5.11 Ichor Medical Systems
5.11.1 Ichor Medical Systems Profile
5.11.2 Ichor Medical Systems Main Business
5.11.3 Ichor Medical Systems Biochemical Befense Products, Services and Solutions
5.11.4 Ichor Medical Systems Biochemical Befense Revenue (US$ Million) & (2018-2023)
5.11.5 Ichor Medical Systems Recent Developments
5.12 Aeolus Pharmaceuticals
5.12.1 Aeolus Pharmaceuticals Profile
5.12.2 Aeolus Pharmaceuticals Main Business
5.12.3 Aeolus Pharmaceuticals Biochemical Befense Products, Services and Solutions
5.12.4 Aeolus Pharmaceuticals Biochemical Befense Revenue (US$ Million) & (2018-2023)
5.12.5 Aeolus Pharmaceuticals Recent Developments
5.13 Achaogen
5.13.1 Achaogen Profile
5.13.2 Achaogen Main Business
5.13.3 Achaogen Biochemical Befense Products, Services and Solutions
5.13.4 Achaogen Biochemical Befense Revenue (US$ Million) & (2018-2023)
5.13.5 Achaogen Recent Developments
5.14 Elusys Therapeutics
5.14.1 Elusys Therapeutics Profile
5.14.2 Elusys Therapeutics Main Business
5.14.3 Elusys Therapeutics Biochemical Befense Products, Services and Solutions
5.14.4 Elusys Therapeutics Biochemical Befense Revenue (US$ Million) & (2018-2023)
5.14.5 Elusys Therapeutics Recent Developments
5.15 Dynavax Technologies
5.15.1 Dynavax Technologies Profile
5.15.2 Dynavax Technologies Main Business
5.15.3 Dynavax Technologies Biochemical Befense Products, Services and Solutions
5.15.4 Dynavax Technologies Biochemical Befense Revenue (US$ Million) & (2018-2023)
5.15.5 Dynavax Technologies Recent Developments
5.16 Cleveland BioLabs
5.16.1 Cleveland BioLabs Profile
5.16.2 Cleveland BioLabs Main Business
5.16.3 Cleveland BioLabs Biochemical Befense Products, Services and Solutions
5.16.4 Cleveland BioLabs Biochemical Befense Revenue (US$ Million) & (2018-2023)
5.16.5 Cleveland BioLabs Recent Developments
5.17 Soligenix
5.17.1 Soligenix Profile
5.17.2 Soligenix Main Business
5.17.3 Soligenix Biochemical Befense Products, Services and Solutions
5.17.4 Soligenix Biochemical Befense Revenue (US$ Million) & (2018-2023)
5.17.5 Soligenix Recent Developments
5.18 Alnylam Pharmaceuticals
5.18.1 Alnylam Pharmaceuticals Profile
5.18.2 Alnylam Pharmaceuticals Main Business
5.18.3 Alnylam Pharmaceuticals Biochemical Befense Products, Services and Solutions
5.18.4 Alnylam Pharmaceuticals Biochemical Befense Revenue (US$ Million) & (2018-2023)
5.18.5 Alnylam Pharmaceuticals Recent Developments
6 North America
6.1 North America Biochemical Befense Market Size by Country (2018-2033)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Biochemical Befense Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Biochemical Befense Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Biochemical Befense Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Biochemical Befense Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Biochemical Befense Market Dynamics
11.1 Biochemical Befense Industry Trends
11.2 Biochemical Befense Market Drivers
11.3 Biochemical Befense Market Challenges
11.4 Biochemical Befense Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Biochemical Befense Market Size (US$ Million) Comparison by Region 2018 VS 2023 VS 2033
Table 2. Global Biochemical Befense Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Biochemical Befense Market Size Share by Region (2018-2023)
Table 4. Global Biochemical Befense Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global Biochemical Befense Forecasted Market Size Share by Region (2024-2033)
Table 6. Global Biochemical Befense Market Size (US$ Million) by Type: 2018 VS 2023 VS 2033
Table 7. Global Biochemical Befense Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Biochemical Befense Revenue Market Share by Type (2018-2023)
Table 9. Global Biochemical Befense Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global Biochemical Befense Revenue Market Share by Type (2024-2033)
Table 11. North America Biochemical Befense Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Biochemical Befense Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe Biochemical Befense Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Biochemical Befense Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific Biochemical Befense Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Biochemical Befense Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America Biochemical Befense Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Biochemical Befense Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa Biochemical Befense Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Biochemical Befense Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global Biochemical Befense Market Size (US$ Million) by Application: 2018 VS 2023 VS 2033
Table 22. Global Biochemical Befense Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Biochemical Befense Revenue Market Share by Application (2018-2023)
Table 24. Global Biochemical Befense Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global Biochemical Befense Revenue Market Share by Application (2024-2033)
Table 26. North America Biochemical Befense Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Biochemical Befense Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe Biochemical Befense Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Biochemical Befense Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific Biochemical Befense Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Biochemical Befense Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America Biochemical Befense Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Biochemical Befense Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa Biochemical Befense Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Biochemical Befense Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global Biochemical Befense Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Biochemical Befense Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biochemical Befense as of 2023)
Table 39. Date of Key Players Enter into Biochemical Befense Market
Table 40. Global Biochemical Befense Key Players Headquarters and Area Served
Table 41. Biochemical Befense Product Solution and Service
Table 42. Global Biochemical Befense Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Emergent Biosolutions Basic Information List
Table 45. Emergent Biosolutions Description and Business Overview
Table 46. Emergent Biosolutions Biochemical Befense Products, Services and Solutions
Table 47. Revenue (US$ Million) in Biochemical Befense Business of Emergent Biosolutions (2018-2023)
Table 48. Emergent Biosolutions Recent Developments
Table 49. Hytest Basic Information List
Table 50. Hytest Description and Business Overview
Table 51. Hytest Biochemical Befense Products, Services and Solutions
Table 52. Revenue (US$ Million) in Biochemical Befense Business of Hytest (2018-2023)
Table 53. Hytest Recent Developments
Table 54. GSK Basic Information List
Table 55. GSK Description and Business Overview
Table 56. GSK Biochemical Befense Products, Services and Solutions
Table 57. Revenue (US$ Million) in Biochemical Befense Business of GSK (2018-2023)
Table 58. GSK Recent Developments
Table 59. Sanofi Basic Information List
Table 60. Sanofi Description and Business Overview
Table 61. Sanofi Biochemical Befense Products, Services and Solutions
Table 62. Revenue (US$ Million) in Biochemical Befense Business of Sanofi (2018-2023)
Table 63. Sanofi Recent Developments
Table 64. PharmAthene Basic Information List
Table 65. PharmAthene Description and Business Overview
Table 66. PharmAthene Biochemical Befense Products, Services and Solutions
Table 67. Revenue (US$ Million) in Biochemical Befense Business of PharmAthene (2018-2023)
Table 68. PharmAthene Recent Developments
Table 69. Bavarian Nordic Basic Information List
Table 70. Bavarian Nordic Description and Business Overview
Table 71. Bavarian Nordic Biochemical Befense Products, Services and Solutions
Table 72. Revenue (US$ Million) in Biochemical Befense Business of Bavarian Nordic (2018-2023)
Table 73. Bavarian Nordic Recent Developments
Table 74. SIGA Technologies Basic Information List
Table 75. SIGA Technologies Description and Business Overview
Table 76. SIGA Technologies Biochemical Befense Products, Services and Solutions
Table 77. Revenue (US$ Million) in Biochemical Befense Business of SIGA Technologies (2018-2023)
Table 78. SIGA Technologies Recent Developments
Table 79. Arbutus Biopharma Basic Information List
Table 80. Arbutus Biopharma Description and Business Overview
Table 81. Arbutus Biopharma Biochemical Befense Products, Services and Solutions
Table 82. Revenue (US$ Million) in Biochemical Befense Business of Arbutus Biopharma (2018-2023)
Table 83. Arbutus Biopharma Recent Developments
Table 84. DynPort Vaccine Basic Information List
Table 85. DynPort Vaccine Description and Business Overview
Table 86. DynPort Vaccine Biochemical Befense Products, Services and Solutions
Table 87. Revenue (US$ Million) in Biochemical Befense Business of DynPort Vaccine (2018-2023)
Table 88. DynPort Vaccine Recent Developments
Table 89. Xoma Corporation Basic Information List
Table 90. Xoma Corporation Description and Business Overview
Table 91. Xoma Corporation Biochemical Befense Products, Services and Solutions
Table 92. Revenue (US$ Million) in Biochemical Befense Business of Xoma Corporation (2018-2023)
Table 93. Xoma Corporation Recent Developments
Table 94. Ichor Medical Systems Basic Information List
Table 95. Ichor Medical Systems Description and Business Overview
Table 96. Ichor Medical Systems Biochemical Befense Products, Services and Solutions
Table 97. Revenue (US$ Million) in Biochemical Befense Business of Ichor Medical Systems (2018-2023)
Table 98. Ichor Medical Systems Recent Developments
Table 99. Aeolus Pharmaceuticals Basic Information List
Table 100. Aeolus Pharmaceuticals Description and Business Overview
Table 101. Aeolus Pharmaceuticals Biochemical Befense Products, Services and Solutions
Table 102. Revenue (US$ Million) in Biochemical Befense Business of Aeolus Pharmaceuticals (2018-2023)
Table 103. Aeolus Pharmaceuticals Recent Developments
Table 104. Achaogen Basic Information List
Table 105. Achaogen Description and Business Overview
Table 106. Achaogen Biochemical Befense Products, Services and Solutions
Table 107. Revenue (US$ Million) in Biochemical Befense Business of Achaogen (2018-2023)
Table 108. Achaogen Recent Developments
Table 109. Elusys Therapeutics Basic Information List
Table 110. Elusys Therapeutics Description and Business Overview
Table 111. Elusys Therapeutics Biochemical Befense Products, Services and Solutions
Table 112. Revenue (US$ Million) in Biochemical Befense Business of Elusys Therapeutics (2018-2023)
Table 113. Elusys Therapeutics Recent Developments
Table 114. Dynavax Technologies Basic Information List
Table 115. Dynavax Technologies Description and Business Overview
Table 116. Dynavax Technologies Biochemical Befense Products, Services and Solutions
Table 117. Revenue (US$ Million) in Biochemical Befense Business of Dynavax Technologies (2018-2023)
Table 118. Dynavax Technologies Recent Developments
Table 119. Cleveland BioLabs Basic Information List
Table 120. Cleveland BioLabs Description and Business Overview
Table 121. Cleveland BioLabs Biochemical Befense Products, Services and Solutions
Table 122. Revenue (US$ Million) in Biochemical Befense Business of Cleveland BioLabs (2018-2023)
Table 123. Cleveland BioLabs Recent Developments
Table 124. Soligenix Basic Information List
Table 125. Soligenix Description and Business Overview
Table 126. Soligenix Biochemical Befense Products, Services and Solutions
Table 127. Revenue (US$ Million) in Biochemical Befense Business of Soligenix (2018-2023)
Table 128. Soligenix Recent Developments
Table 129. Alnylam Pharmaceuticals Basic Information List
Table 130. Alnylam Pharmaceuticals Description and Business Overview
Table 131. Alnylam Pharmaceuticals Biochemical Befense Products, Services and Solutions
Table 132. Revenue (US$ Million) in Biochemical Befense Business of Alnylam Pharmaceuticals (2018-2023)
Table 133. Alnylam Pharmaceuticals Recent Developments
Table 134. North America Biochemical Befense Market Size by Country (2018-2023) & (US$ Million)
Table 135. North America Biochemical Befense Market Size by Country (2024-2033) & (US$ Million)
Table 136. Europe Biochemical Befense Market Size by Country (2018-2023) & (US$ Million)
Table 137. Europe Biochemical Befense Market Size by Country (2024-2033) & (US$ Million)
Table 138. Asia-Pacific Biochemical Befense Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 139. Asia-Pacific Biochemical Befense Market Size by Region (2018-2023) & (US$ Million)
Table 140. Asia-Pacific Biochemical Befense Market Size by Region (2024-2033) & (US$ Million)
Table 141. Asia-Pacific Biochemical Befense Market Share by Region (2018-2023)
Table 142. Asia-Pacific Biochemical Befense Market Share by Region (2024-2033)
Table 143. Latin America Biochemical Befense Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 144. Latin America Biochemical Befense Market Size by Country (2018-2023) & (US$ Million)
Table 145. Latin America Biochemical Befense Market Size by Country (2024-2033) & (US$ Million)
Table 146. Middle East & Africa Biochemical Befense Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 147. Middle East & Africa Biochemical Befense Market Size by Country (2018-2023) & (US$ Million)
Table 148. Middle East & Africa Biochemical Befense Market Size by Country (2024-2033) & (US$ Million)
Table 149. Biochemical Befense Market Trends
Table 150. Biochemical Befense Market Drivers
Table 151. Biochemical Befense Market Challenges
Table 152. Biochemical Befense Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biochemical Befense Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global Biochemical Befense Market Size (US$ Million), 2018 VS 2023 VS 2033
Figure 3. Global Biochemical Befense Market Share by Regions: 2023 VS 2033
Figure 4. Global Biochemical Befense Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America Biochemical Befense Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe Biochemical Befense Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific Biochemical Befense Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America Biochemical Befense Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa Biochemical Befense Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of Anthrax
Figure 11. Global Anthrax Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of Smallpox
Figure 13. Global Smallpox Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Product Picture of Botulism
Figure 15. Global Botulism Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 16. Product Picture of Radiation/Nuclear
Figure 17. Global Radiation/Nuclear Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 18. Product Picture of Others
Figure 19. Global Others Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 20. Global Biochemical Befense Market Size Share by Type: 2023 & 2033
Figure 21. North America Biochemical Befense Revenue Market Share by Type (2018-2033)
Figure 22. Europe Biochemical Befense Revenue Market Share by Type (2018-2033)
Figure 23. Asia-Pacific Biochemical Befense Revenue Market Share by Type (2018-2033)
Figure 24. Latin America Biochemical Befense Revenue Market Share by Type (2018-2033)
Figure 25. Middle East and Africa Biochemical Befense Revenue Market Share by Type (2018-2033)
Figure 26. National Defense Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 27. Military Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 28. Others Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 29. Global Biochemical Befense Market Size Share by Application: 2023 & 2033
Figure 30. North America Biochemical Befense Revenue Market Share by Application (2018-2033)
Figure 31. Europe Biochemical Befense Revenue Market Share by Application (2018-2033)
Figure 32. Asia-Pacific Biochemical Befense Revenue Market Share by Application (2018-2033)
Figure 33. Latin America Biochemical Befense Revenue Market Share by Application (2018-2033)
Figure 34. Middle East and Africa Biochemical Befense Revenue Market Share by Application (2018-2033)
Figure 35. Biochemical Befense Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2023
Figure 36. Global Top 5 and Top 10 Players Biochemical Befense Market Share in 2023
Figure 37. North America Biochemical Befense Market Share by Country (2018-2033)
Figure 38. United States Biochemical Befense Market Size (2018-2033) & (US$ Million)
Figure 39. Canada Biochemical Befense Market Size (2018-2033) & (US$ Million)
Figure 40. Germany Biochemical Befense Market Size (2018-2033) & (US$ Million)
Figure 41. France Biochemical Befense Market Size (2018-2033) & (US$ Million)
Figure 42. U.K. Biochemical Befense Market Size (2018-2033) & (US$ Million)
Figure 43. Italy Biochemical Befense Market Size (2018-2033) & (US$ Million)
Figure 44. Russia Biochemical Befense Market Size (2018-2033) & (US$ Million)
Figure 45. Nordic Countries Biochemical Befense Market Size (2018-2033) & (US$ Million)
Figure 46. Asia-Pacific Biochemical Befense Market Share by Region (2018-2033)
Figure 47. China Biochemical Befense Market Size (2018-2033) & (US$ Million)
Figure 48. Japan Biochemical Befense Market Size (2018-2033) & (US$ Million)
Figure 49. South Korea Biochemical Befense Market Size (2018-2033) & (US$ Million)
Figure 50. Southeast Asia Biochemical Befense Market Size (2018-2033) & (US$ Million)
Figure 51. India Biochemical Befense Market Size (2018-2033) & (US$ Million)
Figure 52. Australia Biochemical Befense Market Size (2018-2033) & (US$ Million)
Figure 53. Latin America Biochemical Befense Market Share by Country (2018-2033)
Figure 54. Mexico Biochemical Befense Market Size (2018-2033) & (US$ Million)
Figure 55. Brazil Biochemical Befense Market Size (2018-2033) & (US$ Million)
Figure 56. Middle East & Africa Biochemical Befense Market Share by Country (2018-2033)
Figure 57. Turkey Biochemical Befense Market Size (2018-2033) & (US$ Million)
Figure 58. Saudi Arabia Biochemical Befense Market Size (2018-2033) & (US$ Million)
Figure 59. UAE Biochemical Befense Market Size (2018-2033) & (US$ Million)
Figure 60. Bottom-up and Top-down Approaches for This Report